Literature DB >> 2168520

Cloning and expression of human and rat D1 dopamine receptors.

Q Y Zhou1, D K Grandy, L Thambi, J A Kushner, H H Van Tol, R Cone, D Pribnow, J Salon, J R Bunzow, O Civelli.   

Abstract

The importance of the dopaminergic system in brain function has been emphasized by its association with neurological and psychiatric disorders such as Parkinson's disease and schizophrenia. On the basis of their biochemical and pharmacological characteristics, dopamine receptors are classified into D1 and D2 subtypes. As the most abundant dopamine receptor in the central nervous system, D1 receptors seem to mediate some behavioural responses, modulate activity of D2 dopamine receptors, and regulate neuron growth and differentiation. The D dopamine receptor has been cloned by low-stringency screening. We report here the cloning of human and rat D1 dopamine receptors by applying an approach based on the polymerase chain reaction. The cloned human D1 dopamine receptor has been characterized on the basis of four criteria: the deduced amino-acid sequence, which reveals that it is a G protein-coupled receptor; the tissue distribution of its messenger RNA, which is compatible with that of the D1 dopamine receptor; its pharmacological profile when transfected into COS-7 cells; and its ability to stimulate the accumulation of cyclic AMP in human 293 cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168520     DOI: 10.1038/347076a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  71 in total

1.  Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding.

Authors:  Elisabetta Daré; Serguei Fetissov; Tomas Hökfelt; Håkan Hall; Sven Ove Ogren; Sandra Ceccatelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-09       Impact factor: 3.000

2.  Molecular modelling of D2-like dopamine receptors.

Authors:  C D Livingstone; P G Strange; L H Naylor
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

3.  Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment.

Authors:  P R Buckland; M C O'Donovan; P McGuffin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 4.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

Review 5.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 6.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

7.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission.

Authors:  R T Fremeau; G E Duncan; M G Fornaretto; A Dearry; J A Gingrich; G R Breese; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Identification of novel catecholamine absorbing proteins in the central nervous system.

Authors:  G M Ross; B E McCarry; S Thakur; R K Mishra
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

9.  Depression of high-threshold calcium currents by activation of human D2 (short) dopamine receptors expressed in differentiated NG108-15 cells.

Authors:  G R Seabrook; G McAllister; M R Knowles; J Myers; H Sinclair; S Patel; S B Freedman; J A Kemp
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

Review 10.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.